Foster Group’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Foster Group's RDY Position: Q2 2026 in Review
Foster Group reduced its Dr. Reddy's Laboratories (RDY) stake by 30% in Q2 2026, selling an estimated $90.4K and leaving 15,893 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #287.
Foster Group first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $341K in Q2 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Foster Group held 15,893 shares of Dr. Reddy's Laboratories worth $230K as of Q2 2026.
- Foster Group sold 6,702 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $90.4K.
- Dr. Reddy's Laboratories made up 0.01% of Foster Group's portfolio in Q2 2026, its #287 holding.
- Foster Group first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
- Foster Group's Dr. Reddy's Laboratories position peaked at $341K in Q2 2025.
- 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.